721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study

Basso, U.;Paolieri, F.;Porta, C. G.;De Giorgi, U.;Bracarda, S.;Antonuzzo, L.;Atzori, F.;Cartenì, G.;Procopio, G.;Fratino, L.;D'Arcangelo, M.;Fornarini, G.;Zucali, P. A.;Cusmai, A.;Santoni, M.;Baldessari, C.;Naglieri, E.;Panni, S.;Zagonel, V.;Tortora, G.

2020-01-01